• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926012220
Device Problem Occlusion Within Device (1423)
Patient Problems Thrombus (2101); Sudden Cardiac Death (2510)
Event Date 03/09/2017
Event Type  Death  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
Same case as mdr id# 2134265-2017-04352, 2134265-2017-04353 and 2134265-2017-04354.(b)(4) study.It was reported that patient death and in-stent thrombus occurred.In (b)(6) 2016, the patient was referred for cardiac catheterization and subsequently the index procedure was performed.Target lesion #1 was located in the mid left anterior descending artery (lad) with 70% stenosis and was 26 mm long with a reference vessel diameter of 2.50 mm.Target lesion #1 was treated with pre-dilatation and placement of a 2.25 x 38 mm synergy ii stent.Following post dilatation, the residual stenosis was 0%.Target lesion #2 was located in the proximal lad with 80% stenosis and was 20 mm long with a reference vessel diameter of 3.00 mm.Target lesion #2 was treated with pre-dilatation and placement of a 2.5 x 28 mm synergy ii stent.Following post dilatation, the residual stenosis was 0%.Target lesion #3 was located in the first obtue marginal branch (om1) with 80% stenosis and was 16 mm long with a reference vessel diameter of 2.25 mm.Target lesion #3 was treated with pre-dilatation and placement of a 2.25 x 16 mm and a 2.25 x 12 mm synergy ii stent with 0% residual stenosis.The following day, the subject was discharged on dual antiplatelet therapy.In (b)(6) 2017, the patient expired at home due to sudden "cardiac death", assumed to be attributable to de novo coronary thrombosis or in-stent coronary thrombosis, approximately 36 hours after stopping the anti-platelet drug plavix (clopidogrel).No death certificate is available and autopsy was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6534587
MDR Text Key74094400
Report Number2134265-2017-04355
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840022
UDI-Public(01)08714729840022(17)20170621(10)19443466
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/01/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/21/2017
Device Model NumberH7493926012220
Device Catalogue Number39260-1222
Device Lot Number19443466
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/17/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/17/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age83 YR
-
-